NCT07517523

Brief Summary

Ventricular arrhythmias are a serious complication of myocardial infarction. The aim of this study is to provide reliable data on the management and mortality associated with ventricular arrhythmia in the setting of acute myocardial infarction.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
14mo left

Started Jun 2025

Typical duration for all trials

Geographic Reach
1 country

8 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress49%
Jun 2025Oct 2027

Study Start

First participant enrolled

June 20, 2025

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

January 11, 2026

Completed
3 months until next milestone

First Posted

Study publicly available on registry

April 8, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2027

Last Updated

May 28, 2026

Status Verified

April 1, 2026

Enrollment Period

1.3 years

First QC Date

January 11, 2026

Last Update Submit

May 26, 2026

Conditions

Keywords

ST-segment elevation myocardial infarctionnon-ST-segment elevation myocardial infarctionventricular fibrillationventricular tachycardiacardiac arrestimplantable cardioverter defibrillator

Outcome Measures

Primary Outcomes (1)

  • Post-discharge mortality

    through study completion, an average of 2 years

Secondary Outcomes (9)

  • Baseline demographic and clinical characteristics at inclusion

    At baseline

  • Number of participants fot each type of myocardial infarction

    At baseline

  • Number of participants with each ventricular arrhythmia characteristic and management strategy during index hospitalization

    At baseline

  • In-hospital mortality

    From admission until the date of death or hospital discharge, whichever came first, assessed up to 28 days

  • Number of participants with wearable cardioverter-defibrillator utilization

    At baseline

  • +4 more secondary outcomes

Study Arms (1)

Ventricular arrhythmia

patients who developed a sustained ventricular arrhythmia (ventricular tachycardia or ventricular fibrillation) during the acute phase of myocardial infarction, i.e., from infarct onset to hospital discharge

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All included individuals will be consecutive patients who developed a sustained ventricular arrhythmia during the acute phase of a myocardial infarction between January 1, 2012, and April 14, 2024.

You may qualify if:

  • ≥ 18 years
  • Acute myocardial infarction
  • Sustained ventricular arrhythmia (ventricular tachycardia or ventricular fibrillation) at the acute phase of an acute myocardial infarction (before hospital discharge)
  • Between January 1, 2012 and April 14, 2024

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (8)

University hospital of Caen

Caen, France

RECRUITING

University hospital of Dijon

Dijon, France

RECRUITING

University hospital of Grenoble

Grenoble, France

RECRUITING

Hopital Européen Georges Pompidou

Paris, France

RECRUITING

Hospital of Pau

Pau, France

RECRUITING

University hospital of Poitiers

Poitiers, France

RECRUITING

University hospital of Saint Etienne

Saint-Etienne, France

RECRUITING

University hospital of Tours

Tours, France

RECRUITING

MeSH Terms

Conditions

ST Elevation Myocardial InfarctionVentricular FibrillationTachycardia, VentricularHeart Arrest

Condition Hierarchy (Ancestors)

Myocardial InfarctionMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosisArrhythmias, CardiacTachycardiaCardiac Conduction System Disease

Study Officials

  • Rodrigue Garcia, MD; PhD

    Cardiology department and CIC 1402; University Hospital of Poitiers

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 11, 2026

First Posted

April 8, 2026

Study Start

June 20, 2025

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

October 1, 2027

Last Updated

May 28, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations